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The structural basis of bacterial manganese import
Stephanie L. Neville1†, Jennie Sjöhamn2†‡, Jacinta A. Watts1†, Hugo MacDermott-Opeskin3, 
Stephen J. Fairweather3,4, Katherine Ganio1, Alex Carey Hulyer1, Aaron P. McGrath2§,  
Andrew J. Hayes1, Tess R. Malcolm5, Mark R. Davies1, Norimichi Nomura6, So Iwata6,7,8,  
Megan L. O’Mara3, Megan J. Maher2,5*, Christopher A. McDevitt1*
Metal ions are essential for all forms of life. In prokaryotes, ATP-binding cassette (ABC) permeases serve as the 
primary import pathway for many micronutrients including the first-row transition metal manganese. However, 
the structural features of ionic metal transporting ABC permeases have remained undefined. Here, we present the 
crystal structure of the manganese transporter PsaBC from Streptococcus pneumoniae in an open-inward confor-
mation. The type II transporter has a tightly closed transmembrane channel due to “extracellular gating” residues 
that prevent water permeation or ion reflux. Below these residues, the channel contains a hitherto unreported 
metal coordination site, which is essential for manganese translocation. Mutagenesis of the extracellular gate 
perturbs manganese uptake, while coordination site mutagenesis abolishes import. These structural features are 
highly conserved in metal-specific ABC transporters and are represented throughout the kingdoms of life. Collec-
tively, our results define the structure of PsaBC and reveal the features required for divalent cation transport.
INTRODUCTION
The first-row transition element manganese (Mn) is essential for 
life (1,  2). Manganese serves crucial roles in biological systems 
where it provides structural stability and/or catalytic activity for 
metalloproteins involved in diverse processes such as regulating 
carbon metabolism, oxidative stress tolerance, and, in pathogens, 
evasion of host defenses (3). Import of Mn2+ in prokaryotes is primarily 
facilitated by adenosine 5′-triphosphate (ATP)–binding cassette (ABC) 
permeases, although natural resistance-associated macrophage pro-
tein (NRAMP) and P-type adenosine triphosphatases (ATPases) have 
been shown to also contribute in specific microorganisms (4). Irrespec-
tive of the protein architecture, metal ion acquisition requires 
shielding of the charge from the lipid bilayer to enable transmem-
brane translocation. This can be achieved through the formation of 
metal chelate complexes as occurs in the import of iron (siderophore 
and heme), cobalt (cobalamin), and, in some instances, zinc (Zn; 
zincophore). However, a subset of type II ABC permeases directly 
transport ionic metals, such as Mn2+ and Zn2+, into the cytoplasm, 
although there remains a paucity of information on the structural 
and molecular properties that facilitate this process.
Type II ABC permeases associated with metal ion import are 
composed of an ABC transporter, formed by two transmembrane 
domains (TMDs), two cytoplasmic nucleotide binding domains 
(NBDs), and an extra-cytoplasmic solute binding protein (SBP). 
The SBPs have high affinities for metal ion substrates, typically in 
the nanomolar to micromolar range (5), enabling efficacious capture 
in the extra-cytoplasmic space. SBP-mediated metal ion delivery to 
the transporter, in concert with ATP-driven active transport via the 
ABC transporter, provides an efficient pathway for the scavenging 
of poorly abundant environmental substrates (6). In the globally sig-
nificant Gram-positive bacterial pathogen Streptococcus pneumoniae 
(the pneumococcus), PsaBCA is the type II ABC permease respon-
sible for Mn2+ acquisition. S. pneumoniae has an absolute require-
ment for Mn2+ to mediate virulence and in vivo disease, and this is 
reflected in the near-absolute amino acid conservation of PsaC 
(TMD; 99.74%), PsaB (NBD; 99.91%), and PsaA (SBP; 99.83%) in 
an analysis of more than 20,000 pneumococcal genomes (fig. S1) 
(7). The structural and mechanistic features of PsaA that contribute 
to Mn2+ selectivity have been characterized (8, 9), while the contri-
bution of PsaBC remains undefined. Here, we aimed to determine 
the structure of PsaBC to elucidate the mechanistic bases of metal 
ion specificity and translocation.
RESULTS AND DISCUSSION
Recombinant wild-type (WT) PsaBC and a spontaneous PsaBC variant 
(PsaC:Phe100Ser) were screened for overexpression, purification, and 
crystallization. The F100SPsaBC protein was successfully crystallized 
in two forms: (i) as a F100SPsaBC-Fab complex in space group C2221 
and (ii) F100SPsaBC alone in space group P1 (Fig. 1, A to C). Despite 
extensive efforts, WTPsaBC (either in complex with a Fab or alone) 
did not produce crystals suitable for data collection and structure 
solution. Refinements to 2.85- and 2.9-Å resolution, respectively, 
converged with residuals R = 23.8 and Rfree = 27.1 for F100SPsaBC-
Fab and R = 26.0 and Rfree = 28.1 for F100SPsaBC. The final models 
show excellent geometries (table S1) (10).
The F100SPsaBC variant retained ATPase activity comparable to 
WTPsaBC, although Mn2+ transport functionality was impaired 
(Fig. 1, E to G). Notably, the ATPase activities of WTPsaBC and the 
F100SPsaBC variant were not stimulated by the presence of PsaA 
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Fig. 1. Structure and activity of the PsaBC transporter. (A) F100SPsaB2C2-Fab2 complex (space group C2221; PsaC, blue and lavender; PsaB, hot and light pink; Fabs, gray). 
(B) F100SPsaB2C2 structure [space group P1; colored as in (A)]. (C) Superposition of F100SPsaB2C2-Fab2 and F100SPsaB2C2 structures [F100SPsaB2C2-Fab2 colored as in (B); 
F100SPsaB2C2 in gray]. Fabs omitted for clarity. (D) MD snapshot of WTPsaB2C2 [colored as in (A)] in a PG and CDL membrane. Headgroups of lipid species (PG, yellow; CDL 
species, orange) are shown as spheres with tails hidden. (E) ATPase activity of reconstituted WTPsaBC and F100SPsaBC with Mn2+ and/or PsaA. Data represent means (± SEM) 
from at least four independent experiments. (F) Growth of WT S. pneumoniae (D39 rpsl+), the isogenic mutant, and complemented strains () in Mn2+-limited media. Data 
represent means (± SD) absorbance measurements from three independent experiments. (G) Mn2+ accumulation of S. pneumoniae strains in Mn2+-limited media. Data 
represent means (± SD) from three independent experiments. Statistical significance was determined by one-way analysis of variance (ANOVA) with Tukey posttest 
P > 0.05, not significant (ns); ****P < 0.0001. (H) PsaC (from F100SPsaB2C2) with helices represented as cylinders. One monomer is colored gray, the other is colored from 
blue (N terminus) to red (C terminus). (I) Topology of PsaC monomers with helices numbered (AH, amphipathic helix; EG, extracellular gate; CH, coupling helix). Colors 
correspond to (H).
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and/or Mn2+ (Fig. 1E). This observation is similar to other charac-
terized type II ABC importers wherein the ATPase activity has been 
shown to be relatively uncoupled from the substrate occupancy 
status of the SBP (11–13). This is in stark contrast to type I ABC 
importers (14) and highlights the critical importance of metal ion 
release kinetics from the SBP PsaA (8, 9, 15) in contributing to 
specificity of permease import. The isogenic S. pneumoniae D39 
F100SPsaBC strain grew in Mn2+-limited media (Fig. 1F), but at a 
reduced growth rate and with significantly decreased Mn2+ accu-
mulation relative to the WT and complemented strains, although to 
a lesser extent than the isogenic psaC deletion strain (Fig. 1G). This 
is attributable to the F100S mutation most likely affecting the di-
mensions and/or polarity of the translocation pore, rather than a 
significant structural change in the presence of the mutation [see 
discussion of molecular dynamics (MD) analyses below].
In the C2221 structure, there is a single F100SPsaBC-Fab complex 
per asymmetric unit, with the F100SPsaB2C2-Fab2 assembly generated 
by the application of crystallographic symmetry operators (Fig. 1A). 
The Fab fragments associate exclusively with the PsaB protomers 
(fig. S3A) through two surface-located helices (residues 109 to 122 
and 174 to 184), with a total buried surface area for PsaB of 1033 Å2. 
All crystal packing contacts throughout the crystal are mediated 
through Fab-Fab interactions (fig. S3B).
The F100SPsaBC structure shows four F100SPsaB2C2 assemblies 
per asymmetric unit (Fig. 1B). Although the crystals of F100SPsaBC 
were grown in the presence of adenylyl-imidodiphosphate (AMP-
PNP) and MgCl2, there was no electron density to indicate the pres-
ence of bound nucleotide in the crystal. The F100SPsaB2C2 unit from 
the F100SPsaBC-Fab structure superposes with each equivalent as-
sembly within the asymmetric unit of the F100SPsaBC structure with 
an average root mean squared deviation (RMSD) of 0.9 Å, indicat-
ing only minor differences between the F100SPsaB2C2 assemblies 
within the F100SPsaBC-Fab and F100SPsaBC structures. Therefore, 
Fab binding results in minimal structural perturbations (Fig. 1C). 
In addition, each F100SPsaBC unit superposes with other F100SPsaBC 
assemblies within the asymmetric unit with an average RMSD of 
0.5 Å (for 500 common C positions), indicating that all chains 
have very similar overall structures. Given these similarities, a single 
tetramer will be described to represent all F100SPsaB2C2 complexes 
for the P1 structure and used for the MD simulations of F100SPsaB2C2.
To identify any differences between the F100SPsaBC and WTPsaBC 
structures, an in silico reverse mutation was performed on the 
F100SPsaB2C2 structure to recover WTPsaB2C2. MD simulations (eight 
500-ns replicas) were then performed for each structure embedded 
in a solvated S. pneumoniae membrane (16–18) composed of a 2:1 
ratio of phosphatidylglycerol (PG) and cardiolipin (CDL) to assess 
the stabilities of the protein complexes in a membrane environment 
(Fig. 1D). The trajectories were combined, and the resulting analysis 
showed an average C RMSD of 3.0 ± 0.3 Å for the membrane- 
embedded protein complexes relative to their respective starting 
structures. Cluster analysis of the MD simulations showed that both 
WTPsaB2C2 and F100SPsaB2C2 complexes populated the same confor-
mational cluster, as defined by a cutoff RMSD of 3.0 Å, for 96.7% of 
the total simulation time (cluster 1; fig. S2). The remaining 3.3% of 
the combined trajectories sampled three further conformational 
clusters, which are primarily attributable to changes in the relative 
orientations of flexible loop regions (clusters 2 to 4; fig. S2). Collec-
tively, the MD analyses indicate that the WTPsaB2C2 and F100SPsaB2C2 
complexes are stable in MD simulations, and both adopt the same 
overall conformation (movies S1 and S2). Further, the predicted 
structures in the membrane, with calculated RMSD values, are in-
dicative of thermal fluctuations and no apparent global changes in 
protein conformation.
The F100SPsaB2C2 dimer contains 18 transmembrane helices 
(nine per protomer; Fig. 1H), a short N-terminal amphipathic helix, 
an extracellular gate (EG) helix, and two coupling helices (CH1 and 
CH2; Fig. 1I) and is relatively symmetrical. The F100SPsaC mono-
mers dimerize through interactions between TM2, TM4 (including 
the EG helix), TM7, and TM9. TM2 (residues 41 to 62), TM4 (resi-
dues 92 to 113), and the EG (residues 117 to 125) line the ~30-Å-long 
translocation pathway (Fig. 2, A and B), which is created by the di-
merization. Residues Ser117 and Thr118 are positioned at the extra-
cellular surface of the translocation pore, with the entrance lined by 
residues Phe121, Leu124, and Phe125 from the EG, with - stacking 
between Phe121 and Phe125 (Fig. 2A). The roles of the EG residues 
Phe121 and Phe125 were investigated by mutagenesis. Phenotypic 
characterization of the isogenic S. pneumoniae mutant strains re-
vealed that both the F121A and F125A strains were significantly 
perturbed for Mn2+ accumulation and growth under Mn2+-limited 
conditions relative to control strains (fig. S4).
Below the pore entrance, the channel is restricted by the side 
chains of residues Leu104 (TM4) and Ile199 (from the loop bridging 
TM7 and TM8; Fig. 2, A to C). The diameter of the pore at this point 
reduces to 0.7 Å (Fig. 2B). Given the ionic radius of Mn2+ (0.83 Å), 
“closure” of the pore through this cluster of residues likely prevents 
adventitious entry of other cationic solutes (Mg2+ = 0.72 Å, Ca2+ = 
1.00 Å, Fe2+ = 0.78 Å, Cu2+ = 0.73 Å, and Zn2+ = 0.74 Å) or water 
(H2O  =  2.75 Å) and/or prevents “reflux” of the Mn2+ ion during 
permeation. Thus, the narrow pore aperture in the F100SPsaBC crys-
tal structure renders the translocation pathway effectively closed 
with respect to membrane permeation. This is supported by solva-
tion analyses (eight 500-ns replicas) of the translocation pathway 
(Fig. 2D), which shows that the extracellular surface of the translo-
cation pathway is exposed to bulk solvent, but water is completely 
excluded by the EG and the restriction point below. Water perme-
ation increases and approaches bulk solvation below the restriction 
point, indicative of an “inward-open” conformation for F100SPsaBC 
(19, 20). This conformation has been described for the structures of 
BhuUV, BhuUV-T (19) (Burkholderia cenocepacia), and MolAB 
(20) (Haemophilus influenzae) complexes, for which the periplas-
mic gates are also described as “closed.” The restriction of the trans-
location pathway in the BhuUV-T structure is mediated by both a 
hydrophobic interaction and a salt bridge (between residues Asp200 
and Arg204) (19). Although the inward facing conformation of type II 
permeases was initially suggested to be an unstable and short-lived 
state (21), its repeated observation indicates that it may be a stable, 
resting state for some transporters.
On the cytoplasmic side of the pore restriction, at a distance of 
~4.5 Å, is a negatively charged cavity, where residues Asp46 and 
His50 from each F100SPsaC monomer are located (Fig. 2, A and E, 
and fig. S5). This combination of residues is highly conserved in the 
TMDs of 52 functionally characterized Mn2+- and Zn2+-translocating 
ABC importers (Fig. 2A and fig. S6). This raises the possibility 
that these residues interact with the cation as part of the mechanism 
for metal ion translocation. In this conformation of the transporter, 
these residues are positioned 3.0 to 3.4 Å from the center of the 
translocation channel through which the Mn2+ ion traverses. Rela-
tively subtle movements of TM2, facilitated by nucleotide and/or 
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PsaA binding, would position these side chains within the typical 
coordination distances (1.8 to 2.3 Å) associated with Mn2+-protein 
complexes (22). Therefore, we refer to this cluster of residues as a 
coordination site (CS). We investigated the role of the CS residues 
by mutagenesis. Although mutation of the residues did not influence 
coupling of the PsaBC ATPase activity in the presence of Mn2+-PsaA 
(Fig. 2F), the isogenic S. pneumoniae mutant strains showed severely 
perturbed growth and Mn2+ accumulation in Mn2+-limited medium 
(Fig. 2, G and H). Together, these data show that the CS residues 
play a critical role in facilitating cytoplasmic Mn2+ acquisition.
“Selectivity filters” have been observed in the structures of a 
number of ion channels and transporters which translocate ionic 
substrates across the membrane. In these systems, the common 
mechanism for divalent ion selection involves complementary elec-
trostatic interactions between channel residues and the cationic 
substrate. For example, in the Cav1.1 ion channel, rings of four Glu 
residues and eight carbonyl oxygens provide a Ca2+ selective filter 
(23). Likewise, in the cardiac RyR, three rings each containing four 
acidic residues select for the permeation of solvated Ca2+ ions (24). 
In P-type ATPases such as the sarcoplasmic reticulum Ca2+ ATPase, 
polar interactions between Ca2+ ions and the carbonyl groups and 
side chains of surrounding amino acids have been observed (25).
Transition metal ion channels and transporters use additional 
metal coordination interactions, rather than solely relying upon 
electrostatics, to facilitate membrane traversal. For example, the 
eukaryotic Cu+ channel Ctr1 includes two rings of Met residues that 
are proposed to specifically coordinate Cu+ during its translocation, 
providing both a driving force for ion movement and a molecular 
mechanism for selectivity. The crystal structure of the SLC11 
(NRAMP) transporter from Staphylococcus capitis (ScaDMT)—
which transports Fe2+, Mn2+, and Cd2+ ions—includes a metal bind-
ing site composed of Met, Asp, and Asn residues, in addition to the 
Fig. 2. The Mn2+ translocation pathway in PsaBC. (A) Structural elements composing the translocation pathway with Phe121, Leu124, Phe125, Leu104, His50, and Asp46 
shown as sticks. Residue conservation (65 TMDs from 52 characterized transporters; fig. S6) mapped to PsaC (<50%, white; 50 to 100%, white to blue). (B) Volume of the 
F100SPsaB2C2 translocation pathway visualized in purple; arrow denotes 0.7-Å closure. (C) - stacking between Phe121 and Phe125. (D) MD analysis of WTPsaB2C2 in a solvat-
ed membrane (8 × 500-ns simulations). Representative starting (left) and final (right) frames with time-dependent water occupancy displayed as a heat matrix (middle) 
aligned to the structure (dashed lines). PsaB (gray cartoon), PsaC (TM2 and TM4; black ribbons), and water molecules (blue sticks). (E) Representation of PsaB2C2 with 
negatively charged surfaces in red, positive in blue, and uncharged in white. Cutaway reveals the CS (indicated by arrow). (F) ATPase activity of reconstituted D46APsaBCA 
and H50APsaBCA in the presence or absence of Mn2+. Data represent means (± SEM) from three independent experiments. (G) Growth of WT S. pneumoniae (D39 rpsl+) and 
the mutant strains in Mn2+-limited medium. Data represent means (± SD) absorbance measurements from three independent experiments. (H) Mn2+ accumulation of 
S. pneumoniae strains in Mn2+-limited media. Data represent means (± SD) from three independent experiments. Statistical significance was determined by one-way 
ANOVA with Tukey posttest [P > 0.05, not significant (ns); ****P < 0.0001].
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carbonyl group from the polypeptide backbone as coordinating li-
gands. This CS is located in the unwound regions of two symmetry- 
related helices in the center of the bilayer. These residues were 
shown to be fully conserved in this class of transporter (including 
that from human) with their mutagenesis attenuating transport ac-
tivity and metal binding affinities of the transporter (26). Lastly, 
cation diffusion facilitator proteins (CDFs), such as the bacterial 
Zn2+ transporter YiiP, have conserved sequence motifs (combinations 
of Asp and His residues) that coordinate the divalent metal during 
the transport cycle and vary in combination, with an associated al-
teration in the relative metal specificities, between Zn2+ and Mn2+ 
transporters (27, 28).
Succinctly, the observation of ion coordinating residues in the 
translocation pathways of ion channels and transporters is not un-
usual. Further, substrate recognition sites within the translocation 
pathways of type I ABC permeases, such as the Escherichia coli 
maltose transporter MalFGK2, have also been reported (29,  30). 
However, the observation of a binding site within a type II ABC 
transporter is entirely unique, given that prevailing models hold 
that the translocation pathways of these transporters show no affin-
ity for their transported substrates (i.e., that these transporters 
contain “Teflon” cavities) (31). For example, although the BhuUV 
complex transports the iron-chelate heme, no amino acid side 
chains with chemistries compatible with heme iron ligation—such 
as His, Cys, Tyr, or Met—are present within the translocation path-
way. In contrast, we propose that in PsaBC, residues Asp46 and 
His50 form a CS within the Mn2+ translocation pathway, to provide 
an additional degree of specificity for Mn2+ uptake, in addition to 
the precise cation release that occurs via the interaction between 
PsaC and Mn2+-bound PsaA. The presence of both Asp and His res-
idues within the PsaC CS is consistent with the observation of these 
residues in the Zn2+ and Mn2+ binding sites of CDFs (27) and resi-
dues that commonly comprise the active sites of Mn2+-dependent 
enzymes (22).
Below the CS is a cytoplasmic gate, composed of residue Leu43 
from each PsaC protomer, and a pair of Asp93 residues below, 
exposed on the cytoplasmic side of the membrane. These residues 
presumably act to gate and/or drive metal ion translocation to the 
cytoplasm. The interaction between the F100SPsaC and PsaB dimers 
features two PsaC coupling helices (CH1 and CH2; Fig. 1I) that 
extensively interact with the corresponding PsaB protomers. In the 
structures of other type II ABC transporters, these helices have been 
proposed to play a role in the transmission of conformational 
change of the NBDs to the TMDs in response to nucleotide binding 
and hydrolysis (12, 19, 20, 32, 33).
Building on the identification of the CS (within TM2) and the 
EG (within TM4) as features crucial to facilitate cation transloca-
tion within the ABC transporter architecture, we examined the con-
servation of these motifs within the Pfam database of protein 
families (34). PsaC belongs to the ABC-3 transport family [Pfam 
v33.1 identifier PF00950 (34)], for which there are no structures 
publicly available. The ABC-3 transport family (PF00950) is com-
posed of more than 10,000 sequences with an average length of 
251 amino acids (interquartile range, 250 to 269 amino acids) and 
an average identity of 27%. Amino acid likelihood plots derived 
from the ABC-3 family alignment revealed high conservation of the 
TM2-TM4 TMDs across both Eubacteria and Archaea (figs. S7 and 
S8). Further, and in contrast to most of the other prokaryotic ABC 
importers (35), putative transporters encoded by the plastid genomes 
of several glaucophyte and rhodophyte species were also found to 
contain TM2-TM4 homologous regions (fig. S7). With the sole ex-
ception of Porphyridium purpureum, these eukaryotic plastid ge-
nomes were found to lack the PAM71-type and CMT1-type Mn2+ 
transporters common to plastids of other algae and plants (36). Al-
though this is suggestive of a potential functional role for these ABC 
transporters in Mn2+ uptake, it is notable that the plastid genomes 
did not encode a corresponding ortholog for a metal-specific SBP, 
which is required for prokaryotic metal import and is typically en-
coded within the ABC permease operon. This may suggest a mech-
anistic difference in how the algal ABC transporter variants recruit 
putative metal substrates (Mn2+ and/or Zn2+), although definitive 
studies remain to be conducted. Irrespective, the TM2-TM4 struc-
tural elements are highly conserved and appear to have been re-
tained during algal plastid evolution, most likely arising from 
endosymbiotic origin and/or horizontal gene transfer events.
A search of the coordinates of the PsaC structure versus the Pro-
tein Data Bank (PDB) reveals that the most similar structures are 
the TMDs from the type II ABC transporter family (Fig.  3A and 
table S2) (12, 19, 20, 32). However, PsaC has 9 TM helices, whereas 
other members of this family have 10. The reduced number of TM 
helices and the tight packing between PsaC protomers result in an 
overall more compact structure (Fig. 3A). Similarly, the PsaB struc-
ture is not only comparable to the NBDs of the type II ABC trans-
porter family, such as BhuV and BtuD 10,20, but also unexpectedly 
shows similarity to the NBDs of the cobalt energy-coupling trans-
porter from Rhodobacter capsulatus [CbiO (37)] and the unusual 
lipopolysaccharide transporter from E. coli [LptB (38); table S2]. 
Despite the structural similarity between these NBDs, their relative 
orientations are unique. The PsaB subunits and the motifs respon-
sible for nucleotide binding and hydrolysis (i.e., the P loops, Walker 
motifs, and ABC signatures) are well separated in the PsaBC struc-
ture, so that they are offset relative to each other, parallel to the 
membrane plane [the distance between the C atoms of PsaB resi-
dues 40 (P loop) and 136 (ABC motif) is ~25 Å; Fig. 3A]. This is 
substantially different from the positioning of the structurally ho-
mologous NBDs in the BhuUV (19) complex where the P loop and 
ABC motif are well aligned for nucleotide binding {the equivalent 
distance in the BhuUV structure [PDB 5B58 (19)] is ~8.5 Å; Fig. 3B}. 
In the case of PsaBC, a substantial realignment of the PsaB mono-
mers would therefore be required for ATP binding and hydrolysis. 
Given that the association of Mn2+-PsaA with the PsaBC transporter 
appears uncoupled from the ATP hydrolysis, nucleotide binding 
rather than SBP docking most likely drives this rearrangement. 
However, the alignment of the NBDs would require a substantial 
movement (~15 Å) of both these domains and the TMDs, which 
may be linked to the relatively low rate of ATP hydrolysis observed 
for PsaBC.
The structure of F100SPsaBC provides an original snapshot of the 
mechanisms by which very small (<150 Da), charged entities, such 
as transition metal ions, are translocated across biological mem-
branes in a specific and exquisitely controlled manner. Specificity 
for Mn2+ transport by PsaBC is engendered by the combination of 
metal ion binding and release kinetics by the SBP PsaA and the 
unique features of the type II ABC transporter PsaBC. Distinct from 
other type II transporters characterized to date, metal import is 
controlled and reflux prevented, by closure of the transmembrane 
pore in the inward-open conformation of the transporter. Inward 
transport of the metal ion is achieved by virtue of the CS within the 
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translocation pathway and the combination of the uncoupling and 
slow rate of ATP hydrolysis, which can likely be attributed to the 
unusual relative positioning of the NBDs. The selective acquisition 
of specific transition metal ions is essential to fundamental chemi-
cal processes in biological systems throughout the kingdoms of life. 
In contrast to other nutrients transported by ABC permeases—such 
as sugars, amino acids, peptides, vitamins, and osmolytes—metal 
ions are not “consumed” within cells. Hence, their uptake is precise-
ly controlled according to the intracellular requirements, dictated 
by the tight regulation of permease expression, with the only other 
regulatory mechanisms arising through the actions of metal ion ef-
flux pathways. The structure of PsaBC encapsulates the molecular 
mechanisms by which a delicate balance of cellular metal ion re-
quirements can be achieved. Further, it highlights the structural and 
mechanistic diversity that exists within the ABC transporter super-
family. To date, the mechanistic differences within the type II ABC 
transporter grouping have been proposed to arise from the differ-
ences in substrate size, based on comparisons between the BtuCD 
(vitamin B12; 1355 Da) and MolBC (molybdate; 159 Da) transporters 
(33), although further structures are required to clarify the veracity 
of this inference. The structural and functional insights provided by 
PsaBC expand our knowledge of variations to the type II transport 
mechanism (fig. S9) and, crucially, potentially represent a new 
transporter class, comprising cation translocation elements present 
in all the kingdoms of life (39).
MATERIALS AND METHODS
Materials
Tryptone and yeast extract were purchased from Bacto (NSW, 
Australia). Complete, EDTA-free protease inhibitor tablets were obtained 
from Roche (Sigma-Aldrich, NSW, Australia). Deoxyribonuclease I 
from bovine pancreas was purchased from Sigma-Aldrich (NSW, 
Australia). n-Dodecyl--d-maltopyranoside (DDM) was obtained 
from Anatrace (Ohio, USA). Ni Sepharose high-performance histidine- 
tagged protein purification resin (HP resin) was purchased from 
GE Healthcare (NSW, Australia). Total E. coli lipid extract and egg 
l-- phosphatidylcholine (egg PC) were obtained from Avanti Polar 
Lipids (Alabama, USA). Transition metal ion salts manganese(II) 
sulfate monohydrate, zinc(II) sulfate heptahydrate, copper(II) sulfate 
heptahydrate, cobalt(II) chloride, and nickel(II) chloride were purchased 
from Sigma-Aldrich (NSW, Australia). The Transcreener ADP2 
FP Assay Kit was obtained from Bellbrook Labs (Wisconsin, USA).
Bacterial strains, culturing, and growth experiments
The S. pneumoniae mutant strains (table S3) were constructed using 
the Janus cassette (40). Briefly, the rpsL gene of S. pneumoniae D39 
was replaced with a streptomycin-resistant allele (D39 rpsl+) to allow 
counter selection. The upstream and downstream flanking regions 
of psaC were then amplified using primers (table S4) with comple-
mentarity to the Janus cassette and were joined to the Janus cassette 
by overlap extension polymerase chain reaction (PCR). These linear 
fragments were used to replace psaC in the S. pneumoniae D39 
chromosome by homologous recombination. Exchange of the Janus 
cassette with mutant variants of psaC was achieved via homologous 
recombination. S. pneumoniae WT and mutant strains were rou-
tinely grown at 37°C with 5% CO2 on blood agar [39 g liter−1 
Columbia base agar (Oxoid) and 5% (v/v) defibrinated horse blood] 
or in THY [Todd-Hewitt broth (Oxoid) and 0.5% (w/v) Bacto yeast 
extract (Becton Dickinson and Company)]. For phenotypic assays, 
including growth kinetic assays and metal accumulation analyses, 
S. pneumoniae strains were grown in a Mn2+-limited cation-defined 
Fig. 3. Comparison of the F100SPsaB2C2 structure with those of other permeases. (A) The structures of the TMDs of F100SPsaB2C2 and homologs are shown in cartoon 
representations, with one monomer colored gray and the other from blue at the N terminus to red at the C terminus. Helices are shown as cylinders. The bottom repre-
sentation is a rotation of the top view by 90°, parallel to the membrane plane. From left to right: F100SPsaC (this work), BtuC (32) (E. coli; PDB 1L7V), MolA (20) (H. influenzae; 
PDB 2NQ2), BhuU (19) (B. cenocepacia; PDB 5B58), and HmuU (12) (Yersinia pestis; PDB 4G1U). (B) Alignment of the NBD structures. From left to right: PsaB (this work), BhuV 
23 (PDB 5B58), and CbiO 35 (R. capsulatus; PDB 5X40). In all panels, the NBD monomers are shown in magenta and light pink, and the ABC, Walker B, and P loop residues 
are highlighted in dark blue. For the CbiO structure, the bound nucleotide and magnesium ion are shown as gray spheres.
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medium with casein hydrolysate and 0.5% yeast extract, as de-
scribed previously (41). Metal content of the Mn2+-limited medium 
was determined by inductively coupled plasma mass spectrometry 
(ICP-MS) on an Agilent 8900 Triple Quadrupole ICP-MS as previ-
ously described (8, 42) with the Mn2+-limited cation-defined medium 
routinely containing <1 M Mn2+. Growth media were supplemented 
with the following antibiotics (Merck) where appropriate: erythro-
mycin (0.2 g ml−1), chloramphenicol (6 g ml−1), streptomycin 
(150 g ml−1), gentamicin (5 g ml−1), or kanamycin (50 g ml−1). 
E. coli strains were routinely grown at 37°C in LB broth or on LB 
1.5% agar plates supplemented with kanamycin (50 g ml−1) to 
maintain plasmids. Growth kinetic assays were performed using 
cultures of S. pneumoniae D39 and mutant variants prepared from 
overnight growth on blood agar supplemented with 30 M Mn2+ 
and appropriate antibiotics, resuspended, and inoculated into the 
Mn2+-limited medium to an optical density at 600 nm (OD600) of 
0.05. The culture was incubated at 37°C + 5% CO2 and grown to 
OD600 = 0.3. Growth kinetic assays were conducted in a 96-well 
plate format using a FLUOstar Omega spectrophotometer (BMG 
Labtech). S. pneumoniae were inoculated in a final volume of 200 l 
in the Mn2+-limited medium (± supplementation where indicated) 
to a starting OD600 = 0.01 in a clear 96-well plate (Greiner). The 
plate was incubated at 37°C + 5% CO2 for >16 hours, with readings 
taken every 30 min. All analyses were carried out to at least n = 5 
biological replicates and data analyzed using GraphPad Prism 
(version 8).
Protein expression and purification
Sequences encoding psaB (UniProtKB, A0A0H2ZNF3) and psaC 
(UniProtKB, A0A0H2ZPI2) were amplified using standard PCR as 
overlapping open reading frames from S. pneumoniae D39 genomic 
DNA using the primers 5pPsaXhoI and 3pPsaKpnI (table S4). The 
amplified psaBC insert was gel purified, digested, and ligated into 
predigested pWaldo vector (43) between Xho I and Kpn I restric-
tions sites, upstream of a sequence encoding a tobacco etch virus (TEV) 
protease site and enhanced green fluorescent protein (eGFP)– 8xHis. 
The resultant vector was used to concurrently express the untagged 
PsaB and the PsaC protein that was attached to a C-terminal fusion 
of eGFP-8xHis. This cloning strategy resulted in two constructs en-
coding (i) the WT PsaBC sequence (pWALDO-WTPsaBC) and (ii) a 
“spontaneous” mutant in PsaC, F100S (pWALDO-F100SPsaBC) 
(table S5). The WTPsaBC-TEV-GFP-His and F100SPsaBC-TEV-GFP-
His proteins were overexpressed in E. coli BL21 (DE3) cells grown 
at 37°C in LB, supplemented with kanamycin (100 g ml−1) to an 
OD600 of 0.6, induced with isopropyl -d-1-thiogalactopyranoside 
(0.2 mM), and harvested after 16 hours at 16°C. Cell pellets were 
suspended in binding buffer {20 mM tris-HCl (pH 8.0), 200 mM 
NaCl, and 1 mM TCEP [tris(2-carboxyethyl) phosphine hydrochlo-
ride]} and disrupted by passage through a TS series bench-top cell 
disruptor (Constant Systems Ltd.) at 35 kpsi. The membrane frac-
tion was pelleted by ultracentrifugation (158,000g, 90 min, 4°C; 
Beckman Coulter Type 45 Ti rotor). The isolated membranes were 
resuspended in binding buffer [80 ml, 20 mM tris-HCl (pH 8.0), 
200 mM NaCl, and 1 mM TCEP] and stirred at 4°C (1 hour) in the 
presence of DDM [1% (w/v) final concentration; Anatrace], fol-
lowed by centrifugation (158,000g, 30 min, 4°C). The resulting su-
pernatant (membrane extract) was incubated with Ni-Sepharose 6 
Fast Flow resin (20 ml, GE Healthcare) preequilibrated with bind-
ing buffer, with stirring at 4°C (60 min). The resin was washed with 
increasing concentrations of sodium imidazole (20 and 40 mM, 
respectively) in DDM detergent buffer [20 mM tris-HCl (pH 8.0), 
200 mM NaCl, 1 mM TCEP, and 0.03% (w/v) DDM] before elution 
(250 mM sodium imidazole in DDM detergent buffer).
To cleave the GFP-His tag from the F100SPsaBC-GFP-His fusion, 
TEV protease (5 mg) was added to the eluted protein, and the pro-
tein mixture was dialyzed against DDM detergent buffer (2 liters) at 
4°C overnight. The cleaved F100SPsaBC protein was separated from 
the uncleaved species by reverse binding to Ni-Sepharose 6 Fast 
Flow resin (1 ml), preequilibrated with DDM detergent buffer. The 
F100SPsaBC protein was concentrated to a volume of 5 ml [100-kDa 
molecular weight cutoff (MWCO) Amicon Ultra concentrator, 
Merck Millipore] and injected onto a HiLoad 16/60 Superdex 200-pg 
column (GE Healthcare), preequilibrated with Cymal-6 detergent 
buffer [20 mM tris-HCl (pH 8.0), 200 mM NaCl, 1 mM TCEP, and 
0.1% (w/v) Cymal-6 (Anatrace)]. The main peak fraction was con-
centrated to 20 mg ml−1 (100-kDa MWCO Amicon Ultra concen-
trator, Merck Millipore) before storage of the purified protein 
at −80°C.
Whole-cell ICP-MS
Elemental analysis of S. pneumoniae D39 and the mutant variants 
was performed in the Mn2+-limited medium using culturing condi-
tions described above. Bacterial cells were harvested at OD600 ~0.3 
and then washed twice with phosphate-buffered saline (PBS) + 5 mM 
EDTA and twice with PBS. Cells were again pelleted, the superna-
tant was removed, and the pellet was desiccated overnight on a heat 
block at 96°C. Metal ion content was released by treatment with 
1 ml of 35% nitric acid (HNO3, Suprapur, Merck) at 96°C for 1 hour. 
Metal content was analyzed on an Agilent 8900 Triple Quadrupole 
ICP-MS (42, 44). Bacterial growth for ICP-MS analyses was per-
formed with two technical replicates in three independent biologi-
cal experiments.
Fab generation and purification of the 
F100SPsaBC-fab complex
All the animal experiments conformed to the guidelines of the 
Guide for the Care and Use of Laboratory Animals of Japan and 
were approved by the Kyoto University Animal Experimentation 
Committee (approval number MedKyo18078). Mouse monoclonal 
antibodies against F100SPsaBC were raised according to the previous 
method (45). Briefly, a proteoliposome antigen was prepared by re-
constituting purified, functional F100SPsaBC at high density into 
phospholipid vesicles consisting of a 10:1 mixture of egg PC (Avanti 
Polar Lipids) and the adjuvant lipid A (Sigma-Aldrich) to facilitate 
immune response. BALB/c mice were immunized with the proteoli-
posome antigen using three injections at 2-week intervals. Antibody- 
producing hybridoma cell lines were generated using a conventional 
fusion protocol. Hybridoma clones producing antibodies recognizing 
conformational epitopes in F100SPsaBC were selected by an enzyme- 
linked immunosorbent assay (ELISA) on immobilized phospholipid 
vesicles containing purified F100SPsaBC (liposome ELISA), allowing 
positive selection of the antibodies that recognized the native confor-
mation of F100SPsaBC. Additional screening for reduced antibody 
binding to SDS-denatured F100SPsaBC was used for negative selec-
tion against linear epitope-recognizing antibodies. Stable complex 
formation between F100SPsaBC and each antibody clone was checked 
using fluorescence-detection size exclusion chromatography. Whole 
immunoglobulin G molecules, collected from the large-scale culture 
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supernatant of monoclonal hybridomas and purified using protein G 
affinity chromatography, were digested with papain, and Fab frag-
ments were isolated using a HiLoad 16/600 Superdex 200 pg gel fil-
tration column followed by protein A affinity chromatography. The 
sequence of the Fab was determined via standard 5′ rapid amplifi-
cation of complementary DNA ends using total RNA isolated from 
hybridoma cells.
The F100SPsaBC-Fab complex was generated by incubating 
F100SPsaBC (2.0 mg) with 2.0 molar equivalents of purified Fab on 
ice (1 hour), followed by separation of the F100SPsaBC-Fab complex 
from Fab alone by size exclusion chromatography (Superdex 200 
Increase 10/300 GL, GE Healthcare) in Cymal-6 detergent buffer. 
Fractions confirmed to contain the complex were pooled and con-
centrated to 10 mg ml−1 for crystallization trials.
Protein crystallization and data collection
Crystallization trials for the F100SPsaBC protein and the F100SPsaBC-
Fab complex were conducted using commercially available screens 
(MemGold and MemGold2, Molecular Dimensions) (46, 47) by sit-
ting drop vapor diffusion in 96-well plates (Molecular Dimensions) 
using protein samples at 10 mg ml−1 in Cymal-6 detergent buffer. 
Crystallization drops, consisting of equal volumes (0.2 l) of reser-
voir and protein solutions, were dispensed using a Crystal Gryphon 
Liquid Handling System (Art Robbins Instruments) and were equil-
ibrated against a reservoir of screen solution (50 l). Plates were 
incubated at 20°C.
Optimization of initial crystallization conditions was carried out 
by hanging-drop vapor diffusion in 24-well VDX plates (Hampton 
Research). Diffraction-quality crystals of F100SPsaBC grew after 4 to 
7 days at 20°C by hanging-drop vapor diffusion with drops contain-
ing equal volumes (1 l) of F100SPsaBC [10 mg ml−1, in Cymal-6 deter-
gent buffer, 1 mM AMP-PNP (Sigma-Aldrich), and 5 mM MgCl2] and 
crystallization solution [0.1 M MES (pH 6.5), 0.2 M CaCl2·2H2O, 
and 33% (v/v) PEG400] equilibrated against crystallization solution 
(500 l). The F100SPsaBC-Fab complex was crystallized at 20°C by 
hanging-drop vapor diffusion with drops consisting of equal volumes 
(1 l) of protein (10 mg ml−1 in Cymal-6 detergent buffer) and res-
ervoir solution [50 mM tris-HCl (pH 8.5) and 28% (v/v) PEG400]. 
Both the F100SPsaBC and F100SPsaBC-Fab crystals were flash-cooled 
in liquid nitrogen before data collection.
Diffraction data were recorded on a Dectris Pilatus 6M detec-
tor at the Stanford Synchrotron Radiation Laboratory, beamline 
12-2. All data were collected at 100  K and were processed and 
scaled with HKL2000 (48). Data collection statistics are detailed 
in table S1.
Structure determination and refinement
The F100SPsaBC-Fab complex structure was solved by molecular replace-
ment (MR) using PHASER with models derived from the NBD of the 
MolAB transporter (PDB 2NQ2) (20) and a synthetic Fab (PDB 2R8S) 
(49). The PsaBC component of the refined structure of F100SPsaBC-Fab 
was used to solve the structure of F100SPsaBC by MR using PHASER. Both 
structures were refined with REFMAC5 and PHENIX, using aniso-
tropically corrected diffraction data with translation/liberation/screw 
(TLS), and manual model building was carried out with COOT 
(50). Tight non-crystallographic symmetry (NCS) restraints were 
applied for early cycles of refinement for the F100SPsaBC structure 
and were released for the final cycles. The quality of the structures 
was determined with MOLPROBITY (table S1) (10).
Reconstitution of PsaBC into proteoliposomes
Expression of WTPsaBC and mutant derivatives thereof for reconsti-
tution and characterization used a GST-PsaBC-GFP-His fusion 
protein derived from the parental pWALDO-WTPsaBC construct 
(table S5) and were purified using the protocol described above. 
PsaBC fusion proteins were incorporated into preformed proteoli-
posomes, composed of E. coli lipids:egg PC (3:1), using the previ-
ously described methods (11, 51). Recombinant PsaA, purified 
using the established method (8), and Mn2+ were incorporated into 
proteoliposome lumens by freeze-thaw cycling. Reconstitution effi-
ciency of PsaBC averaged 62.1 ± 3.2%, corresponding to 1.24 mg 
of PsaBC per 100 mg of lipid. PsaA was incorporated into proteo-
liposomes at a 50-fold molar excess of PsaBC, corresponding to 
a concentration of 13.1 to 25.0 M, while Mn2+ was enclosed at 
a 10-fold molar excess relative to PsaA (131 to 250 M). Michaelis- 
Menten parameters of the ATPase activity were determined by 
measuring the increase in concentration of adenosine 5′-diphosphate 
(ADP) as a function of ATP concentration (0.15 to 2 mM). ATPase 
activity was determined using the Transcreener ADP2 FP Assay 
Kit (Bellbrook), wherein liberated ADP binds preferentially to 
an antibody-ADP- fluorophore complex. Activity was quantified 
in the presence or absence of PsaA and Mn2+ with background 
correction performed relative to empty proteoliposomes. TEV 
cleavage of the fusion tags did not significantly affect reconstitution 
efficiency or relative ATPase activity. All experiments were re-
peated at least three times, and data were fitted to Michaelis-Menten 
kinetics to calculate Km and Vmax values using GraphPad Prism 
(version 8).
PsaBCA conservation analysis
A global database of 20,020 publicly available S. pneumoniae genome 
sequences derived from the Global Pneumococcal Sequencing project 
(www.pneumogen.net) (7) was assembled by the Wellcome Sanger 
Institute Pathogen Informatics pipeline (52). The S. pneumoniae 
D39 genome (National Center for Biotechnology Information iden-
tifier NC_008533) served as the reference genome to determine the 
presence, amino acid sequence, and alignment of spd_1461 (psaB), 
spd_1462 (psaC), and spd_1463 (psaA) across the 20,020 clinical 
isolates using the screen_assembly script (53) and BLASTN v2.9.0 
with parameters of 80% coverage and 80% identity. Amino acid 
variation was determined using MUSCLE alignment in Geneious 
Prime (54, 55). Sequence conservation was determined by the per-
centage of variant amino acids compared to consensus.
Sequence conservation within known cation importers
Sixty-five sequences of the TMDs from 52 functionally character-
ized bacterial cation ABC transporters (table S6) were curated, and 
a multiple sequence alignment was performed using hmmalign 
(www.hmmer.org; hmmer version 3.3.1), with the ABC-3.hmm 
from Pfam PF00950 supplied as the alignment model (data file S2) 
(34). The sequence alignment corresponding to chains F and H of 
the S. pneumoniae PsaC (Spn_PsaC) structure was loaded into 
UCSF Chimera (56) to visualize sequence conservation relative to 
protein structure. Percent conservation of residues was then visual-
ized with the command rangecolor mavPercentConserved 50 white 
100 blue. The alignment was also used to generate an hmm for pro-
duction of a logoplot using skylign.org (57). Full alignments in 
aligned FASTA format are provided in data file S1. Alignments 
were visualized using Jalview with identity coloring (58).
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Sequence conservation of PF00950
The hmm from PF00950 (data file S2) was used to generate a logo-
plot using skylign.org (57). Logoplot was generated using informa-
tion above background and consensus coloring. To determine the 
raw conservation of each residue within the 10,041 sequences iden-
tified in PF00950, the aligned sequences were obtained from PFAM 
and conservation mapped to the corresponding residues in the 
S. pneumoniae PsaC structure. Percent conservation of residues was 
then visualized with the command rangecolor mavPercentConserved 
30 white 90 blue. These represented the average (30) and maximum 
(90) % conservation in the alignment.
To visualize the conservation of the PF00950 family across do-
mains, representative sequences of bacteria, archaea, and eukaryote 
(algal plastid) sequences were obtained from UniProt (table S6). These 
include the 12 available algal plastid sequences for rhodophytes and 
glaucophytes, while representative archaea sequences (n = 7) were 
obtained by searching for ABC-3 protein family sequences and select-
ing the sequences with a predicted gene identity and function consistent 
with a cation transporter. Eubacterial sequences (n = 12) were se-
lected from the alignment of the 65 sequences above (data file S3) 
with differing species and gene IDs prioritized for diversity. Multiple 
sequence alignment was performed using hmmalign (www.hmmer.
org; hmmer version 3.3.1), with the ABC-3.hmm from PF00950 
supplied as the alignment model (data file S2).
Simulation methodology
All simulation in this work was conducted using GROMACS2018 
(59–61) under periodic boundary conditions, with the GROMOS 
54A7 forcefield (62). The temperature of the system was maintained 
at 310 K by coupling to an external bath using the Bussi thermostat 
(63) with a temperature coupling constant of 0.1 ps. The lipid and 
nonlipid components of the system were coupled separately. The 
pressure of the system was maintained at 1 bar with semi-isotropic 
pressure coupling and a coupling constant of 0.5 ps. A Berendsen 
barostat (64) was used for equilibration to ensure stabilization of 
the box volume, followed by a Parrinello-Rahman barostat (65, 66) 
for production simulation. A timestep of 2 fs was used for all 
simulations along with the LINCS algorithm (67) to constrain all 
hydrogen-heavy atom bonds. Nonbonded interactions were calculated 
using the particle mesh Ewald (PME) method and a Verlet scheme, 
with a single cutoff of 1.4 nm for both the van der Waals and PME 
real-space sum.
Development of a Gram-positive model bilayer
To embed PsaBC in a near-native lipid environment, a Gram- positive 
bacterial membrane was constructed on the basis of the lipid com-
position of S. pneumoniae, composed primarily of anionic lipid 
species PG and CDL (16–18). The PG-to-CDL ratio was determined 
to be ~2:1, based on radiolabeling studies of P headgroups in PG 
and CDL (18). Saturated and monounsaturated acyl tail lengths of 
18, 16, and 14 carbons are the most abundant in S. pneumoniae (68). 
To satisfy the PG:CDL ratio and most abundant tails, a five-component 
PG and CDL bilayer was used. The 1-palmitoyl-2-oleoyl-sn-glycero- 
3-phosphoglycerol (POPG) parameters defined by Kukol (69) were 
used to construct the following three PG species: PG1(18∆7,16), 
PG2(18∆7,18), and PG3(14,16). Torsionals defined by Bachar and 
co-workers (70) were incorporated at unsaturated positions. CDL 
species were obtained by joining two molecules of PG, and any 
missing parameters were obtained from the GROMOS 54A7 parameter 
set (62). The following CDL species were constructed for use in the 
model bilayer: CDL1(14,16,16∆9,16) and CDL2(16,16∆7,18∆9,18). 
Final ratios for the lipid species were 2:1:1:1:1 for PG1, PG2, PG3, 
CL1, and CL2, respectively. Individual lipids were energy minimized 
in vacuo using the steepest descent minimization. A small system 
with inter-leaflet symmetry and a total of 108 lipids (54 per leaflet) 
were prepared for equilibration. The system was solvated with ap-
proximately 85 simple point charge (SPC) model waters per lipid to 
ensure equilibration of solvent dynamics at the lipid interface and 
neutralized with sodium ions. A 250-ns simulation was conducted 
to equilibrate the small bilayer. The equilibrated small bilayer was 
then tiled to form a larger bilayer system with 972 lipids in total and 
was resolvated in a larger cubic box of SPC water and reneutralized. 
The larger system was then simulated for 250 ns to allow for further 
equilibration using the same method described above.
Preparation of PsaBC simulation systems
MD simulations were performed on the biological assembly of 
F100SPsaBC, starting from F100SPsaBC crystallized in the absence of 
Fab. Unresolved residues in each of the two F100SPsaBC structures 
were repaired in SwissPDBview (71). The extended cytoplasmic loop 
of PsaC was symmetrized between chains E and H of the crystal 
structure by grafting the loop from chain E onto chain H and con-
ducting loop minimization in SwissPDBview. Furthermore, in this 
symmetrized F100SPsaBC structure, the reverse S100F mutation was 
performed with SwissPDBview to give WTPsaBC. A separate simu-
lation system was set up for F100SPsaBC and WTPsaBC using the 
same overall procedure. In each case, a copy of PsaBC was embed-
ded in a 500-lipid patch of the Gram-positive bilayer model de-
scribed above, using the program InflateGro2 (72). The system was 
solvated, and counterions were added to ensure charge neutrality 
and a 150 mM NaCl concentration before energy minimization. 
The system was then relaxed in the bilayer using a series of position- 
restrained simulations. Here, series of 4-ns simulations were per-
formed where position restraints were placed on all protein heavy 
atoms using successively decreasing force constants of 500 kJ mol−1 
nm−2, 250 mol−1 nm−2, 100 kJ mol−1 nm−2, and 50 kJ mol−1 nm−2. 
The relaxed structures were given new velocities and simulated for 
eight replicates of 500 ns.
MD analyses
Root mean squared deviation
The RMSD was calculated using the Kabsch algorithm (73), which 
calculates the optimal rotation matrix that minimizes the RMSD 
between two paired sets of points.
Cluster analysis
The unrestrained trajectories for all independent simulation repeats 
initiated from F100SPsaBC crystallized without Fab and the WTPsaBC 
model were concatenated into a single combined trajectory file. To 
determine the relative populations of specific conformations sam-
pled, the trajectories were clustered using the method of Daura and 
co-workers (74). Two conformations were considered neighbors if 
the backbone RMSD between the two conformations was <0.30 nm.
Solvent number volume analysis
Volumetric analysis was conducted using an in-house Python 
script, using the MDTraj 1.9 library (75). Briefly, a vector between 
the center of mass of two groups of residues is defined, giving the 
vector over which the water density is evaluated. A set of grid points 
(Ngrid) is chosen along the vector. At each point, a disc of a specified 
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radial width R is computed and the solvent number density within 
this disc assigned to the corresponding grid interval. Over the total 
grid, this approach calculates the solvent number density in a cylin-
der of specified radius R, with resolution Ngrid along the vector. This 
process is calculated for each frame of the simulation. To evaluate 
the solvent number density within the PsaBC coordination site, the 
two groups used were Asp135 from chain F/H and Ser92 from chain 
F/H with Ngrid = 20 and radial width of 7 Å.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/7/32/eabg3980/DC1
View/request a protocol for this paper from Bio-protocol.
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